These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 15184276

  • 1. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
    Kindermann M, Maack C, Schaller S, Finkler N, Schmidt KI, Läer S, Wuttke H, Schäfers HJ, Böhm M.
    Circulation; 2004 Jun 29; 109(25):3182-90. PubMed ID: 15184276
    [Abstract] [Full Text] [Related]

  • 2. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.
    Pharmacotherapy; 2009 Aug 28; 29(8):883-90. PubMed ID: 19637941
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
    Vittorio TJ, Zolty R, Kasper ME, Khandwalla RM, Hirsh DS, Tseng CH, Jorde UP, Ahuja K.
    J Cardiovasc Pharmacol Ther; 2008 Mar 28; 13(1):51-7. PubMed ID: 18287590
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study.
    Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ.
    J Hypertens; 1996 Apr 28; 14(4):489-94. PubMed ID: 8761899
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M, Ettelbrück S, Rosenkranz S, Maack C, Cremers B, Schlüter KD, Zolk O, Böhm M.
    Cardiovasc Res; 2001 Feb 01; 49(2):371-80. PubMed ID: 11164847
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS, Tenero DM, Baidoo CA, Campanile AM, Harter AH, Boyle D, Danoff TM.
    Am J Cardiol; 2006 Oct 02; 98(7A):17L-26L. PubMed ID: 17023228
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Acute cardiovascular effects and pharmacokinetics of carvedilol in healthy dogs.
    Sawangkoon S, Miyamoto M, Nakayama T, Hamlin RL.
    Am J Vet Res; 2000 Jan 02; 61(1):57-60. PubMed ID: 10630779
    [Abstract] [Full Text] [Related]

  • 15. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun 02; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

  • 16. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M.
    J Am Coll Cardiol; 2001 Oct 02; 38(4):939-46. PubMed ID: 11583862
    [Abstract] [Full Text] [Related]

  • 17. Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
    Molenaar P, Christ T, Ravens U, Kaumann A.
    Cardiovasc Res; 2006 Jan 02; 69(1):128-39. PubMed ID: 16225854
    [Abstract] [Full Text] [Related]

  • 18. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 19. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S, Erol MK, Bozkurt E, Acikel M, Gundogdu F, Atesal S, Senocak H.
    Int J Cardiovasc Imaging; 2007 Oct 02; 23(5):549-55. PubMed ID: 17171429
    [Abstract] [Full Text] [Related]

  • 20. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure?
    Sanderson JE, Leung LY, Chan SK, Yip GW, Fung JW, Yu CM.
    Eur J Heart Fail; 2005 Aug 02; 7(5):874-7. PubMed ID: 16043407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.